American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers
- PMID: 24493721
- PMCID: PMC3940540
- DOI: 10.1200/JCO.2013.50.9257
American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers
Conflict of interest statement
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Comment in
-
Collection and use of family history in oncology clinics.J Clin Oncol. 2014 Oct 10;32(29):3344-5. doi: 10.1200/JCO.2014.56.4336. Epub 2014 Sep 2. J Clin Oncol. 2014. PMID: 25185094 No abstract available.
-
Important differences between a triage pedigree and risk assessment.J Clin Oncol. 2014 Oct 10;32(29):3345-6. doi: 10.1200/JCO.2014.56.8378. Epub 2014 Sep 2. J Clin Oncol. 2014. PMID: 25185095 No abstract available.
References
-
- Statement of the American Society of Clinical Oncology. Genetic testing for cancer susceptibility, adopted on February 20, 1996. J Clin Oncol. 1996;14:1730–1736. - PubMed
-
- American Society of Clinical Oncology policy statement update. Genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397–2406. - PubMed
-
- Robson ME, Storm CD, Weitzel J, et al. American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2010;28:893–901. - PubMed
-
- Wilson BJ, Qureshi N, Santaguida P, et al. Systematic review: Family history in risk assessment for common diseases. Ann Intern Med. 2009;151:878–885. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
